These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 20851816)

  • 1. Rapid detection of vancomycin-non-susceptible Staphylococcus aureus using the spiral gradient endpoint technique.
    Doddangoudar VC; O'Donoghue MM; Boost MV; Tsang DN; Appelbaum PC
    J Antimicrob Chemother; 2010 Nov; 65(11):2368-72. PubMed ID: 20851816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Etest GRD for the detection of Staphylococcus aureus with reduced susceptibility to glycopeptides.
    Leonard SN; Rossi KL; Newton KL; Rybak MJ
    J Antimicrob Chemother; 2009 Mar; 63(3):489-92. PubMed ID: 19136530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of telavancin against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) in vitro and in an in vivo mouse model of bacteraemia.
    Hegde SS; Skinner R; Lewis SR; Krause KM; Blais J; Benton BM
    J Antimicrob Chemother; 2010 Apr; 65(4):725-8. PubMed ID: 20139142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition and management of infections caused by vancomycin-intermediate Staphylococcus aureus (VISA) and heterogenous VISA (hVISA).
    Howden BP
    Intern Med J; 2005 Dec; 35 Suppl 2():S136-40. PubMed ID: 16271057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The need for accuracy in performing vancomycin intermediate resistant Staphylococcus aureus (VISA) and hetero--VISA detection methods.
    Wootton M
    Int J Antimicrob Agents; 2006 Dec; 28(6):586. PubMed ID: 17049817
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of vancomycin-intermediate Staphylococcus aureus with the updated Trek-Sensititre System and the MicroScan System. Comparison with results from the conventional Etest and CLSI standardized MIC methods.
    Nadarajah R; Post LR; Liu C; Miller SA; Sahm DF; Brooks GF
    Am J Clin Pathol; 2010 Jun; 133(6):844-8. PubMed ID: 20472841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid detection of Staphylococcus aureus strains having reduced susceptibility to vancomycin using a chemiluminescence-based drug-susceptibility test.
    Tajima Y; Komatsu M; Ito T; Hiramatsu K
    J Microbiol Methods; 2007 Sep; 70(3):434-41. PubMed ID: 17655957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).
    Appelbaum PC
    Int J Antimicrob Agents; 2007 Nov; 30(5):398-408. PubMed ID: 17888634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of heterogeneous, intermediate-vancomycin-resistant Staphylococcus aureus (hVISA) using low-concentration vancomycin disks.
    Lulitanond A; Chanawong A; Sribenjalux P; Kaewkes W; Vorachit M; Chongtrakool P; Leumsai D; Monpou P
    Southeast Asian J Trop Med Public Health; 2006 Jul; 37(4):761-7. PubMed ID: 17121303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureus.
    Fritsche TR; Rhomberg PR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):399-403. PubMed ID: 18178361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Be alert to the alterations in the biological characteristics in heterogeneous vancomycin-intermediate Staphylococcus aureus.
    Zhou X; Dai YY; Ma XL
    Indian J Med Microbiol; 2012; 30(2):215-7. PubMed ID: 22664441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid Detection of Vancomycin-Intermediate Staphylococcus aureus by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.
    Mather CA; Werth BJ; Sivagnanam S; SenGupta DJ; Butler-Wu SM
    J Clin Microbiol; 2016 Apr; 54(4):883-90. PubMed ID: 26763961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative proteomics analyses reveal a potential biomarker for the detection of vancomycin-intermediate Staphylococcus aureus strains.
    Drummelsmith J; Winstall E; Bergeron MG; Poirier GG; Ouellette M
    J Proteome Res; 2007 Dec; 6(12):4690-702. PubMed ID: 17997515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection methods for drug-resistant bacteria in routine examination--VISA].
    Kinoshita S; Nakamachi Y
    Rinsho Byori; 2000 Jan; Suppl 111():69-74. PubMed ID: 10804795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital.
    Sancak B; Ercis S; Menemenlioglu D; Colakoglu S; Hasçelik G
    J Antimicrob Chemother; 2005 Sep; 56(3):519-23. PubMed ID: 16046461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The quest to identify heterogeneously resistant vancomycin-intermediate Staphylococcus aureus strains.
    Tenover FC
    Int J Antimicrob Agents; 2010 Oct; 36(4):303-6. PubMed ID: 20674281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous vancomycin resistance in Staphylococcus aureus: a review of epidemiology, diagnosis, and clinical significance.
    Rong SL; Leonard SN
    Ann Pharmacother; 2010 May; 44(5):844-50. PubMed ID: 20332341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a continuum of decreased vancomycin susceptibility in unselected Staphylococcus aureus clinical isolates.
    Hussain FM; Boyle-Vavra S; Shete PB; Daum RS
    J Infect Dis; 2002 Sep; 186(5):661-7. PubMed ID: 12195353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seeking vancomycin resistant Staphylococcus aureus among patients with vancomycin-resistant enterococci.
    Franchi D; Climo MW; Wong AH; Edmond MB; Wenzel RP
    Clin Infect Dis; 1999 Dec; 29(6):1566-8. PubMed ID: 10585815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals.
    Sader HS; Jones RN; Rossi KL; Rybak MJ
    J Antimicrob Chemother; 2009 Nov; 64(5):1024-8. PubMed ID: 19744978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.